Virtual 2021 Fall Scientific Meeting - Living Well to 100: Controlling Periodontitis to Improve Systemic Health

Virtual 2021 Fall Scientific Meeting - Living Well to 100: Controlling Periodontitis to Improve Systemic Health 

Saturday, October 16, 2021

9:00 am - 3:00 pm

Category 2 - 5 CE 

Speaker: Dr. Ken Kornman DDS, PhD
Adjunct Research Professor University of Michigan School of Dentistry

Ken is Editor-in-Chief of the Journal of Periodontology and was co-author of “Staging and Grading of Periodontitis: Framework of a new Classification and Case Definition,” the 2018 paper that describes a new classification of periodontitis approved by the 2017 World Workshop on Periodontal and Peri-implant Diseases.

He has focused on developing genetic tests that add clinical value to prevention and treatment of chronic inflammatory diseases, including periodontitis, cardiovascular disease events, progressive osteoarthritis, and selected cancers. Ken has published more than 150 papers, including papers in Science, New England Journal of Medicine, Journal of the American College of Cardiology, and Human Molecular Genetics. Ken also has more than 35 U.S. patents issued or pending ranging from genetics of chronic diseases and selection of specific drugs for targeted patients.

Ken retains a Research Professor appointment at the University of Michigan and was Professor and Chair of the Department of Periodontics and Professor of Microbiology and Immunology at the University of Texas Health Science Center at San Antonio. He held an adjunct professorship position at Harvard School of Dental Medicine for more than 10 years.

Ken was a founder and Chief Scientific Officer of Interleukin Genetics, Inc, a public molecular diagnostics company for more than 20 years. He is currently CEO of Sitokine Ltd, a molecular diagnostics company based in London focused on prevention of recurrent cardiovascular disease events, and various cancers. Dr Kornman was previously a member of the Board of Visitors of the Graduate School at Duke University. Dr. Kornman has lectured worldwide on the transfer of technology to clinical practice. His mentors were Sigurd Ramfjord, Walter Loesche,  and Harald Loe.

The following topics and subtopics will be addressed:

• What do we know about individuals who live healthy beyond age 90?
• What is currently known about periodontitis association with systemic diseases?
• What has changed that influences how we can help control systemic inflammation?
• How can we modify our treatment of moderate to severe periodontitis to increase the likelihood of reducing systemic inflammation?
• Why should we be convinced that recent breakthroughs indicate that we have something of value to add to our treatment of moderate to severe periodontitis cases?

Learning Objectives:

• Describe multiple paths for periodontitis to influence systemic diseases.
• Name three systemic diseases that have a major chronic inflammatory component
• Does effective treatment of moderate to severe periodontitis improve Type-2-Diabetes (T2D) to the extent that the T2D hemoglobin A1c is reduced sufficiently for the diabetologist to be convinced that the A1c has improved and medications can be reduced?
• If your patient has clinical loss of attachment that exceeds 5mm at multiple interproximal sites, is that sufficient to increase the risk for Type-2-diabetes?
• Discuss dietary factors that predictably reduce systemic inflammation.